The program trains health care providers various youth health specialties to help them treat adolescents holistically and comprehensively. Photo via BCM.edu

A Houston-based training program focused on training leaders in adolescent and young adult health has just received fresh funding to support its cause.

The Baylor College of Medicine-Texas Medical Center Leadership Education in Adolescent Health, or BCM-TMC LEAH, training program has been awarded a five-year grant totaling $2.3 million. The program is one of only seven such training programs funded by the Health Resources and Services Administration and the Maternal and Child Health Bureau.

“Adolescents make up about 20 percent of the U.S. population yet account for disproportionate rates of mortality from accidents, homicides, suicide, and other conditions related to mental illness,” says Dr. Albert C. Hergenroeder, professor and chief of the division of adolescent medicine and sports medicine and project director for BCM-TMC LEAH, in a news release. “The goal is to train and prepare healthcare professionals to assume leadership roles in the development and improvement of the system of care for adolescents and young adults locally, in Texas, in HRSA Region 6 (Oklahoma, New Mexico, Arkansas and Louisiana), and nationally.”

BCM-TMC LEAH provides didactic, experiential, and research-based interdisciplinary education and training, per the news release, across core health disciplines of medicine, nursing, nutrition, psychology, social work, and public health. It's the fourth time since 1997 the program has received funding.

Along with Hergenroeder, Dr. Connie Wiemann, director of research in the division of adolescent medicine and sports medicine, based at Texas Children’s Hospital, is co-director of the program. The two medical professionals also collaborate with:

  • Dr. Diane Santa-Maria, dean and associate professor in the Department of Research at the University of Texas Health Science Center at Houston Cizik School of Nursing
  • Dr. Christine Markham, chair of health promotion and behavioral sciences and deputy director for the Texas Prevention Research Center at University of Texas Health Science Center at Houston School of Public Health
  • Dr. Sarah Norendorf, associate professor and associate dean for research and faculty development
  • Shelley Gonzales, clinical assistant professor and assistant director of field education at the University of Houston Graduate College of Social Work.

“There has been an increased urgency during the last few years of the need to address adolescent health problems, such as suicide, eating disorders and violence in adolescents,” Hergenroeder says. “These problems require solutions for populations as well as individuals.

"For example," Hergenroeder continues, "an individual patient with an eating disorder will require treatment with an interdisciplinary team of physicians, psychologists, nurses, dietitians and social workers yet for a population, the expertise of researchers and public health experts should look at what broader interventions might be used in the prevention of eating disorders. LEAH is designed to give comprehensive training in all aspects of the threats to adolescent and young adult health in the U.S.”

The program trains pre- and postdoctoral students, medicine fellows, and residents by connecting them with faculty across a multitude of related specialized fields. The trainees then go into communities prepared to holistically treat and focus on problems adolescents and young adults are facing, going beyond just physical and mental health.

“The comprehensive training experience also includes a focus on skills to conduct and disseminate research to promote practices and policies that impact adolescents and young adults in a variety of settings,” said Wiemann. "All trainees will learn tools to engage stakeholders and identify opportunities to improve systems of care. In this way, all disciplines play an important role in improving the health and well-being of this population. And healthcare administrative training is incorporated into the LEAH program so that LEAH trainees will be able to successfully execute great research, clinical, teaching and advocacy programs to improve adolescent and young adult health."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Pioneering Houston biotech startup expands to Brazil for next phase

On the Move

Houston biotech company Cemvita has expanded into Brazil. The company officially established a new subsidiary in the country under the same name.

According to an announcement made earlier this month, the expansion aims to capitalize on Brazil’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, which was enacted in 2024. The company said the expansion also aims to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals.

“For decades Brazil has pioneered the bioeconomy, and now the time has come to create the future of the circular bioeconomy,” Moji Karimi, CEO of Cemvita, said in a news release. “Our vision is to combine the innovation Cemvita is known for with Brazil’s expertise and resources to create an ecosystem where waste becomes opportunity and sustainability drives growth. By joining forces with Brazilian partners, Cemvita aims to build on Brazil’s storied history in the bioeconomy while laying the groundwork for a circular and sustainable future.”

The Fuel of the Future Law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

"This is all made possible by our innovative technology, which transforms carbon waste into value,” Marcio Da Silva, VP of Innovation, said in a news release. “Unlike traditional methods, it requires neither a large land footprint nor clean freshwater, ensuring minimal environmental impact. At the same time, it produces high-value green chemicals—such as sustainable oils and biofuels—without competing with the critical resources needed for food production."

In 2024, Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant. As a result, Cemvita quadrupled output at its Houston plant. The company had originally planned to reach this milestone in 2029.

---

This story originally appeared on our sister site, EnergyCapitalHTX.

Texas universities develop innovative open-source platform for cell analysis

picture this

What do labs do when faced with large amounts of imaging data? Powerful cloud computing systems have long been the answer to that question, but a new riposte comes from SPACe.

That’s the name of a new open-source image analysis platform designed by researchers at Baylor College of Medicine, Texas A&M University and the University of Houston.

SPACe, or Swift Phenotypic Analysis of Cells, was created to be used on standard computers that even small labs can access, meaning cellular analysis using images produced through cell painting has a lower barrier to entry than ever before.

“The pharmaceutical industry has been accustomed to simplifying complex data into single metrics. This platform allows us to shift away from that approach and instead capture the full diversity of cellular responses, providing richer, more informative data that can reveal new avenues for drug development,” Michael Mancini, professor of molecular and cellular biology and director of the Gulf Coast Consortium Center for Advanced Microscopy and Image Informatics co-located at Baylor College of Medicine and TAMU Institute for Bioscience and Technology.

SPACe is not only accessible because of its less substantial computational needs. Because the platform is open-source, it’s available to anyone who needs it. And it can be used by academic and pharmaceutical researchers alike.

“The platform allows for the identification of non-toxic effects of drugs, such as alterations in cell shape or effects on specific organelles, which are often overlooked by traditional assays that focus largely on cell viability,” says Fabio Stossi, currently a senior scientist with St. Jude Children’s Research Hospital, the lead author who was at Baylor during the development of SPACe.

The platform is a better means than ever of analyzing thousands of individual cells through automated imaging platforms, thereby better capturing the variability of biological processes. Through that, SPACe allows scientists an enhanced understanding of the interactions between drugs and cells, and does it on standard computers, translating to scientists performing large-scale drug screenings with greater ease.

"This tool could be a game-changer in how we understand cellular biology and discover new drugs. By capturing the full complexity of cellular responses, we are opening new doors for drug discovery that go beyond toxicity,” says Stossi.

And the fact that it’s open-source allows scientists to access SPACe for free right now. Researchers interested in using the platform can access it through Github at github.com/dlabate/SPACe. This early version could already make waves in research, but the team also plans to continually improve their product with the help of collaborations with other institutions.